NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Current Leases (2019 - 2026)

NextPlat's (NXPL) quarterly Current Leases came in at $186000.0 in Q2 2026, down 50.79% year-over-year from $378000.0 in Q2 2025, and down 19.48% quarter-over-quarter from $231000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Current Leases (2019 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Current Leases for 8 consecutive years, with $186000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Leases fell 50.79% year-over-year to $186000.0 in Q2 2026; TTM through Jun 2026 was $186000.0, a 50.79% decrease from a year earlier, with the FY2025 full-year figure at $158000.0, down 60.89% from the prior year.
  • Current Leases was $186000.0 for Q2 2026 at NextPlat, down from $231000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $532000.0 in Q4 2023 and troughed at $11045.0 in Q1 2022.
  • A 5-year average of $293199.0 and a median of $293500.0 in 2025 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases sank 63.65% in 2022 and surged 1780.79% in 2023, its largest moves.
  • Over 5 years, Current Leases stood at $209000.0 in 2022, then jumped by 154.55% to $532000.0 in 2023, then retreated by 24.06% to $404000.0 in 2024, then tumbled by 60.89% to $158000.0 in 2025, then gained by 17.72% to $186000.0 in 2026.
  • The last three Current Leases figures came in at $186000.0 (Q2 2026), $231000.0 (Q1 2026), and $158000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 9.04 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn -
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn -
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 11.82 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 8.80 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 186,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 186,000.00
Mar 31, 2026 231,000.00
Dec 31, 2025 158,000.00
Sep 30, 2025 356,000.00
Jun 30, 2025 378,000.00
Mar 31, 2025 392,000.00
Dec 31, 2024 404,000.00
Sep 30, 2024 381,000.00
Jun 30, 2024 380,000.00
Mar 31, 2024 532,000.00
Dec 31, 2023 532,000.00
Sep 30, 2023 366,494.00
Jun 30, 2023 204,465.00
Mar 31, 2023 207,733.00
Dec 31, 2022 209,000.00
Sep 30, 2022 145,284.00
Jun 30, 2022 203,561.00
Mar 31, 2022 11,045.00
Dec 31, 2021 19,763.00
Sep 30, 2021 27,801.00